Commit To Buy Conatus Pharmaceuticals At $2.50, Earn 9.4% Annualized Using Options
November 15, 2017 at 11:40 AM EST
Investors eyeing a purchase of Conatus Pharmaceuticals Inc (CNAT) stock, but cautious about paying the going market price of $4.07/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the April 2018 put at the $2.50 strike, which has a bid at the time of this writing of 10 cents..